✦ LIBER ✦

Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer

✍ Scribed by Di Maio, Massimo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the Epidermal Growth Facto

✍ Neal Ready 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Analysis of the Prognostic Value of Solu

✍ Eloisa Jantus-Lewintre; Rafael Sirera; Andrea Cabrera; Ana Blasco; Cristina Caba 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 560 KB

Phase II trial of erlotinib in patients

✍ Motoshima, Kohei; Nakamura, Yoichi; Sano, Kazumi; Ikegami, Yoji; Ikeda, Takaya; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 227 KB

9122 POSTER Efficacy of Gefitinib in Pat

✍ Avdiner, A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Clinicopathologic Significance of the Mu

✍ Tomizawa, Y. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 241 KB

Personalized Medicine in Non-Small-Cell

✍ Roberts, P. J.; Stinchcombe, T. E.; Der, C. J.; Socinski, M. A. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 313 KB